Horizon Space Acquisition II Corp.
Status: Closed Deal
U=S+R
R=S/10
| IPO Proceeds, $M | $69.00M |
|---|---|
| IPO Date | Nov 15, 2024 |
| CEO | Mingyu (Michael) Li |
| Left Lead | Maxim |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 12+3+12 |
| IPO Sector | General ▶ |
| IPO Geography | Global |
| Target Company | SL Bio Ltd. |
| Deal Announced | May 12, 2025 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Feb 14, 2026 |
| Amendment Vote | Feb 13, 2026 |
| Closing Date | Jun 12, 2026 |
Formerly HSPT
SLBT
| Price | $5.97 |
|---|---|
| Last closing price | $8.89 |
| H/L, today | $5.68 / $6.99 |
| Volume, today | 1,388,699 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.